Available in all 50 states with some pharmacy restrictions
Auto-renewing plans
Provider Plans
1-Month Plan
TirzepatideMonthly
$145/avg
PharmacyHallandale (503A)
Vials Rx (503A)Greenwich (503A)Align (503A)Boudreaux's New Drug Store (503A)Rush (503A)
AdditivesNone or B3
PreservativeBenzyl Alcohol
BUD (Shelf Life)90 or 180 Days
BillingMonthly
CommitmentNo Commitment
Other FeesNo Extra Fees
Auto-RenewsYes
DoseYour Supply
Your Price
Your Supply
Avg/mo
Your Value
1.5mg/wk6mg/mo
$145.00
6mg
$145
$24.17/mg
3.0mg/wk12mg/mo
$145.00
12mg
$145
$12.08/mg
6.0mg/wk24mg/mo
$145.00
24mg
$145
$6.04/mg
9.0mg/wk36mg/mo
$145.00
36mg
$145
$4.03/mg
11.0mg/wk44mg/mo
$145.00
44mg
$145
$3.30/mg
13.5mg/wk54mg/mo
$145.00
54mg
$145
$2.69/mg
The product page offers a 1-month and a 3-month term behind a selector, and only the 1-month price renders. The 3-month price is not in the page text or its markup, so no 3-month plan is staged rather than one being inferred.
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.